These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7325179)

  • 1. Therapeutic substitution and the hospital formulary system.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1949-51. PubMed ID: 7325179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State regulatory positions concerning therapeutic substitutions in hospitals.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1900-3. PubMed ID: 7325169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic substitution: has its time arrived?
    Doering PL; Russell WL; Klapp DL; McCormick WC
    Hosp Formul; 1984 Sep; 19(9):834-5 ,838-40. PubMed ID: 10267930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive therapeutic interchange program in a community hospital.
    Oh T; Franko TG
    Am J Hosp Pharm; 1991 Jul; 48(7):1471-7. PubMed ID: 1882876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital formulary system/drug product selection: similar or not?
    Fink JL
    Hosp Pharm; 1983 Nov; 18(11):590, 595-6. PubMed ID: 10263897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal and medical issues in therapeutic interchange: implications for pharmacists, physicians, and P & T committees.
    Plumeri PA; Crane VS
    Hosp Formul; 1992 Oct; 27(10):1040-2, 1047-8. PubMed ID: 10121419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaco-legal considerations in the clinical use of decongestants.
    Brushwood DB
    Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 16. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
    Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementing an automatic fluoroquinolone therapeutic interchange program in a community hospital.
    Mioduch HJ
    Hosp Formul; 1992 Sep; 27(9):943-4, 947. PubMed ID: 10128743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.